Purple Biotech (PPBT) Other Working Capital Changes (2017 - 2023)
Purple Biotech has reported Other Working Capital Changes over the past 6 years, most recently at $461000.0 for Q4 2022.
- Quarterly Other Working Capital Changes rose 480.99% to $461000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $313000.0 through Dec 2022, up 199.05% year-over-year, with the annual reading at $153000.0 for FY2025, 59.38% up from the prior year.
- Other Working Capital Changes was $461000.0 for Q4 2022 at Purple Biotech, up from $138000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $848000.0 in Q2 2022 and troughed at -$1.3 million in Q4 2018.
- The 5-year median for Other Working Capital Changes is $19000.0 (2020), against an average of -$115909.1.
- Year-over-year, Other Working Capital Changes crashed 942.06% in 2018 and then surged 480.99% in 2022.
- A 5-year view of Other Working Capital Changes shows it stood at -$1.3 million in 2018, then skyrocketed by 101.68% to $22000.0 in 2019, then dropped by 13.64% to $19000.0 in 2020, then crashed by 736.84% to -$121000.0 in 2021, then surged by 480.99% to $461000.0 in 2022.
- Per Business Quant, the three most recent readings for PPBT's Other Working Capital Changes are $461000.0 (Q4 2022), $138000.0 (Q3 2022), and $848000.0 (Q2 2022).